IL6 and ovarian carcinoma: Furthermore, the EGFR/ERK/NFκB and EGFR/PI3K/NFκB pathways play crucial roles in cancer cell proliferation and invasion, which in turn increase IL6 and IL6R expression in chemo-resistant ovarian cancer cells [168].